Skip to main content

Find Clinical Trials

Home
Conditions
Plaque Psoriasis

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

298 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00691964

Conditions: Plaque Psoriasis
Locations: Site Reference ID/Investigator# 8478 Tucson, Arizona, United States

Site Reference ID/Investigator# 8462 Fresno, California, United States

Site Reference ID/Investigator# 8454 Los Angeles, California, United States

Site Reference ID/Investigator# 8476 Denver, Colorado, United States

View all 35 locations

View Trial Details

Completed

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

NCT00658606

Conditions: Plaque Psoriasis
Locations: Calgary, Alberta, Canada

Surrey, British Columbia, Canada

Vancouver, British Columbia, Canada

St. John's, Newfoundland and Labrador, Canada

View Trial Details

Completed

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

NCT01230138

Conditions: Plaque Psoriasis
Locations: Dermatological Dept., Uniklinikum, TU-Dresden Dresden, Germany

SCIderm Hamburg, Germany

View Trial Details

Completed

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

NCT01373567

Conditions: Plaque Psoriasis
Locations: Durgabai Deshmukh Hospital & Research Center Hyderabad, Andhra Pradesh, India

Postgraduate Institute of Medical Education and Research,Department of Dermatology ,Venerology & Leprology Chandigarh, India

Sheth VS General Hospital, Department of Dermatology Ahmedabad, Gujarat, India

M.S. Diabetes and Shirdi Skin care centre Bangalore, Karnataka, India

View all 23 locations

View Trial Details

Completed

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052

Conditions: Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site San Miguel, Buenos Aires, Argentina

Pfizer Investigational Site Feldkirch, Austria

View all 38 locations

View Trial Details

Completed

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NCT00227240

Conditions: Plaque Psoriasis
Locations: Pfizer Investigational Site Munich, Germany

Pfizer Investigational Site München, Germany

View Trial Details

Completed

Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program

NCT00371774

Conditions: Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Calgary, Alberta, Canada

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

View all 30 locations

View Trial Details

Completed

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

NCT00927069

Conditions: Plaque Psoriasis
Locations: Winnipeg Clinic Winnipeg, Manitoba, Canada

NewLab Clinical Research St. John's, Newfoundland and Labrador, Canada

Mediprobe Research London, Ontario, Canada

The Guenther Dermatology Research center London, Ontario, Canada

View Trial Details

Completed

BTT1023 in Psoriasis

NCT00871598

Conditions: Plaque Psoriasis
Locations: Biotie investigational site Dresden, Germany

Biotie investigational site Leipzig, Germany

Biotie investigational site Berlin, State of Berlin, Germany

Biotie investigational site Berlin, State of Berlin, Germany

View Trial Details

Completed

Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients

NCT00884169

Conditions: Plaque Psoriasis
Locations: St Thomas' Hospital London, United Kingdom

View Trial Details